Literature DB >> 9607798

Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced beta cell death in inbred mice.

J W Cardinal1, D J Allan, D P Cameron.   

Abstract

Inbred strains of mice vary in their sensitivity to the diabetogenic effects of streptozotocin (STZ). To investigate the basis for this strain difference we exposed islet cells from two strains of mice that differ in sensitivity to the drug. We examined them morphologically and measured islet NAD + NADH content, streptozotocin metabolite accumulation, glucose transport capacity, Glut2 levels and medium nitrite accumulation. C57bl/6J mice were more sensitive to STZ than Balb/c mice as judged by the extent of pancreatic insulin depletion and beta cell death, in vivo and in vitro. The mode of cell death was necrosis. After a 30-min in vitro exposure to the drug the more sensitive C57bl/6J islets contained higher levels of streptozotocin metabolites and less NAD + NADH than the more resistant Balb/c islets. The lack of any strain differences in 3-O-methyl glucose transport, Glut2 levels and medium nitrite accumulation suggested that STZ transport and nitric oxide metabolism were not responsible for differences in STZ sensitivity and metabolite accumulation. Thus the strain differences in STZ sensitivity appears to be due to intracellular events within the beta cell occurring after STZ transport and before NAD + NADH depletion. STZ metabolite accumulation appears to be associated with STZ sensitivity. Further studies are warranted to determine if differential STZ metabolite accumulation is responsible for STZ sensitivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607798     DOI: 10.1210/endo.139.6.6048

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Increased susceptibility to streptozotocin-induced beta-cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice.

Authors:  J W Cardinal; G P Margison; K J Mynett; A P Yates; D P Cameron; R H Elder
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Ghrelin improves growth hormone responses to growth hormone-releasing hormone in a streptozotocin-diabetic model of delayed onset.

Authors:  Y Diz-Chaves; C Spuch; D Pérez; F Mallo
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

Review 3.  Advancements and challenges in generating accurate animal models of gestational diabetes mellitus.

Authors:  Raymond C Pasek; Maureen Gannon
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-01       Impact factor: 4.310

4.  Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators.

Authors:  Mahendra Bishnoi; Christine A Bosgraaf; Mruvil Abooj; Linlin Zhong; Louis S Premkumar
Journal:  Mol Pain       Date:  2011-07-27       Impact factor: 3.395

5.  Antidiabetic effect and mode of action of cytopiloyne.

Authors:  Cicero Lee-Tian Chang; Hsien-Yueh Liu; Tien-Fen Kuo; Yi-Jou Hsu; Ming-Yi Shen; Chien-Yuan Pan; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-13       Impact factor: 2.629

6.  Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.

Authors:  Nicolas Damond; Fabrizio Thorel; Julie S Moyers; Maureen J Charron; Patricia M Vuguin; Alvin C Powers; Pedro L Herrera
Journal:  Elife       Date:  2016-04-19       Impact factor: 8.140

7.  Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models.

Authors:  I G Gvazava; O S Rogovaya; M A Borisov; E A Vorotelyak; A V Vasiliev
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.